SecBot SecBot
DEFA14A ·Filed Mar 16, 2026

LXRX

LEXICON PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago SEC0001062822-26-000057
Proxy solicitation materials
Actionable Insight • Neutral

No immediate action is required. Monitor for any follow-up filings that may contain more detailed information about the shareholder vote.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.62
T+0 close · Mar 16, 2026 · via day close
Latest settled
+16.05%
T+60 · $1.88
Vs SPY
+6.19%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 17 $1.62entry
  2. T+1 · 8mo ago −3.70%α −2.31% · $1.56
  3. T+5 · 8mo ago +6.17%α +8.83% · $1.72
  4. T+20 · 7mo ago +14.81%α +10.51% · $1.86
  5. T+60 · 5mo ago +16.05%α +6.19% · $1.88
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Lexicon Pharmaceuticals, Inc. has filed a definitive additional materials proxy statement (DEFA14A) related to a shareholder vote. The filing appears to be routine and does not contain material financial information or indicate an activist campaign.

Key Facts

  • Filing is a DEFA14A, which is a definitive additional materials proxy statement.
  • The filing is routine and does not contain material financial data.
  • No activist campaign or significant corporate action is indicated in the available documents.

Financial Impact

No material financial impact is indicated in the filing.

Risk Factors

  • The filing is routine, but the lack of detailed information in the available documents makes it difficult to assess the specific matters to be voted on.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001062822-26-000057
Document: 0001062822-26-000057-index-headers.html0001062822-26-000057
Document: 0001062822-26-000057-index.html0001062822-26-000057
Document: 0001062822-26-000057.txt0001062822-26-000057

Track record

16 reports on LXRX

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +27.52% at T+20 after the Sep 22, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $1.61 to $1.78 Now $1.75 +8.70% ▲ +10.56% +10.25% vs SPY
  2. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  3. Nov 5, 202611d ago Press Release Neutral 4/10 Entry $1.61 to $1.78 Now $1.75 +8.70% ▲ +10.56% +10.25% vs SPY
  4. Sep 22, 20267w ago Institutional Cluster Bearish 4/10 Entry $2.18 to $2.06 Now $1.75 +19.72% ▲ +5.50% +4.78% vs SPY
  5. Aug 6, 202614w ago 8-K Neutral 5/10 No price data
  6. Aug 6, 202614w ago Press Release Neutral 5/10 Entry $2.36 to $2.47 Now $1.75 −25.85% ▲ +4.66% +4.05% vs SPY
  7. Jun 12, 202622w ago Institutional Cluster Bearish 5/10 Entry $1.92 to $1.96 Now $1.75 +8.85% ▼ −2.08% −0.32% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $1.89 to $1.92 Now $1.75 −7.41% ▲ +1.59% +1.05% vs SPY
  9. May 6, 202627w ago 8-K Neutral 4/10 Entry $1.68 to $1.68 Now $1.75 +4.17% · 0.00% −0.83% vs SPY
  10. Apr 30, 202628w ago 8-K Bearish 6/10 Entry $1.63 to $1.60 Now $1.75 −7.36% ▲ +1.84% +1.50% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 16, 2026